Nine Square Therapeutics
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $4.2M
Investors
- 1
About Nine Square Therapeutics
Based in the US, Nine Square Therapeutics, Inc.Nine Square Therapeutics, Inc. specializes in developing treatments for neurodegenerative diseases. Founded in 2020 by Matt Jacobson and Steve Altschuler, the company is headquartered in South San Francisco, US.5 mn Grant from the Michael J.20 mn.Nine Square Therapeutics primarily focuses on accelerating the development of innovative therapeutics targeting neurodegenerative diseases. Their core offerings revolve around pioneering drug discovery platforms that aim to identify and develop treatments for previously considered undruggable targets. By leveraging advanced scientific methodologies, the company seeks to create solutions that can significantly alter the course of conditions such as Alzheimer's and Parkinson's diseases. The end users of their products include pharmaceutical companies, research institutions, and ultimately, patients suffering from these debilitating ailments.Revenue generation for Nine Square Therapeutics is primarily structured through partnerships and collaborations with pharmaceutical companies and research organizations. These strategic alliances often involve joint ventures on drug development initiatives, where each party shares the financial responsibilities and potential returns associated with bringing new therapies to market. Flagship products derived from their research pipeline are offered under specific licensing agreements, allowing clients to access and implement these innovations in their own therapeutic portfolios. The transaction structure typically encompasses upfront payments, milestone payments based on developmental success, and royalties from the sales of products once they reach commercialization.In September 2023, Nine Square Therapeutics, Inc. Fox Foundation. Future growth plans include the design and launch of new products aimed at addressing critical needs in neurodegenerative diseases, with continued focus on expanding their reach in North America and Europe.
Who invested in Nine Square Therapeutics
1 investor across 2 rounds
See all investors in Nine Square Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nine Square Therapeutics
Who invested in Nine Square Therapeutics?
Nine Square Therapeutics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nine Square Therapeutics raised?
Nine Square Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nine Square Therapeutics last raise money?
Nine Square Therapeutics's most recent round on record is a Series A, in Feb 2021.
What does Nine Square Therapeutics do?
Based in the US, Nine Square Therapeutics, Inc.
Where is Nine Square Therapeutics headquartered?
Nine Square Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Nine Square Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nine Square Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nine Square Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.